Legal status · United States
Is Apelin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Apelin is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
Apelin in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Apelin-13 is an endogenous peptide sold in synthetic form by research suppliers. No approved product exists; recombinant material sold "for research" is an unapproved drug if used in a person. |
| FDA approval status | Not FDA-approved. No apelin peptide or APJ receptor agonist is approved anywhere. Novartis's APJ agonist CLR325 completed a 26-patient phase 2 safety study in heart failure in 2019; native apelin has been given to people only in acute physiology studies. |
| Human studies cited | 6 of 10 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Apelin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Apelin is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Apelin is
A vasodilator and cardiac inotrope in humans, shown by infusion in about 50 people including 18 with heart failure, where its effect was preserved when acetylcholine's was not. The sarcopenia-reversal claim is mouse work; three completed human studies of apelin and insulin sensitivity or cardiovascular effects have never posted results.
Apelin is a family of peptides cut from a 77 amino acid precursor: apelin-36, apelin-31, apelin-28 and apelin-13, with pyroglutamated apelin-13 usually reported as the dominant circulating form. All of them activate the APJ receptor, a class A G protein-coupled receptor also targeted by a second, unrelated ligand called ELABELA.
Mechanism: Established in humans by infusion: apelin peptides cause arterial vasodilatation that depends on nitric oxide (abolished by a nitric oxide clamp, unaffected by aspirin), have no effect on venous tone, increase coronary blood flow and left ventricular contractility, and raise cardiac output while lowering blood pressure and peripheral resistance, in healthy people and in heart failure alike. Established in mice: apelin is induced by muscle contraction, declines with age, and its absence or its receptor's absence produces marked age-related muscle deterioration; restoring it improves muscle function through mitochondrial biogenesis, autophagy, anti-inflammatory signalling and muscle stem cell effects.
Regulatory history: Not FDA-approved. No apelin peptide or APJ receptor agonist is approved anywhere. Novartis's APJ agonist CLR325 completed a 26-patient phase 2 safety study in heart failure in 2019; native apelin has been given to people only in acute physiology studies.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Apelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Apelin in other countries
Frequently asked questions
Is Apelin legal in the United States?
No. Apelin is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile. Note: Apelin-13 is an endogenous peptide sold in synthetic form by research suppliers. No approved product exists; recombinant material sold "for research" is an unapproved drug if used in a person.
Can I buy Apelin in the United States?
No approved product exists to buy. In the United States Apelin is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Apelin-13 is an endogenous peptide sold in synthetic form by research suppliers. No approved product exists; recombinant material sold "for research" is an unapproved drug if used in a person.
Is Apelin FDA approved?
No. FDA status: Not FDA-approved. No apelin peptide or APJ receptor agonist is approved anywhere. Novartis's APJ agonist CLR325 completed a 26-patient phase 2 safety study in heart failure in 2019; native apelin has been given to people only in acute physiology studies.. Current US classification: "Not approved; research use only". On the evidence, 6 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Apelin live on its compound profile.
Apelin profileThis page is general information about the regulatory status of Apelin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.